Latest Breaking News On - Gerhard Dahlhoff

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomCity ofSaqib bashirGerhard dahlhoffOncobeta gmbJane moreyNicola mulhollandTherapeutic nuclear medicineKing college hospitalKing collegeSkin cancer lead at king college hospitalCollege hospitalSkin studyPersonalised irradiation

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomCity ofSaqib bashirGerhard dahlhoffOncobeta gmbJane moreyNicola mulhollandTherapeutic nuclear medicineKing college hospitalKing collegeSkin cancer lead at king college hospitalCollege hospitalSkin studyPersonalised irradiation

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesUnited kingdomCity ofSaqib bashirGerhard dahlhoffOncobeta gmbJane moreyNicola mulhollandTherapeutic nuclear medicineKing college hospitalKing collegeSkin cancer lead at king college hospitalCollege hospitalSkin studyPersonalised irradiation

German skin cancer patients join the EPIC-Skin study

/PRNewswire/ OncoBeta® GmbH has announced University Clinic of Rostock is participating in the global phase IV EPIC-Skin Study (Efficacy of Personalised.

New yorkUnited statesUnited kingdomGerhard dahlhoffShannond brownOncobeta gmbNmscs rostockJane moreyPrnewswire oncobetaTherapeutic nuclear medicineUniversity clinic of rostockMartin heuschkel nuclear medicineUniversity clinicSkin studyPersonalised irradiationMartin heuschkel

Austrian skin cancer patients take part in EPIC-Skin clinical study

/PRNewswire/ OncoBeta® GmbH today announces the first Austrian patients have been treated in the global phase IV EPIC-Skin Study (Efficacy of Personalised.

New yorkUnited statesUnited kingdomSiroos mirazeiGerhard dahlhoffShannond brownOncobeta gmbPrnewswire oncobetaTherapeutic nuclear medicineWorld cancer research fundHead of the nuclear medicine departmentSkin studyPersonalised irradiationNuclear medicineOttakring hospitalPatient reported outcome measures

Latest Breaking News On - Gerhard dahlhoff - Page 2 : vimarsana.com

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study

London skin cancer patients undergo first treatments with OncoBeta s Rhenium-SCT as part of the EPIC-Skin study

German skin cancer patients join the EPIC-Skin study

Austrian skin cancer patients take part in EPIC-Skin clinical study